Nicholas Lydon
| Use attributes for filter ! | |
| Date of birth | February 27,1957 |
|---|---|
| Zodiac sign | Pisces |
| Awards | Japan Prize |
| Fellow of the Royal Society | |
| Date of Reg. | |
| Date of Upd. | |
| ID | 912714 |
About Nicholas Lydon
Nicholas B. Lydon FRS is a British scientist and entrepreneur. In 2009, he was awarded the Lasker Clinical Award and in 2012 the Japan Prize for the development of Gleevec, a selective BCR-ABL inhibitor for the treatment of chronic myeloid leukaemia, which converted a fatal cancer into a manageable chronic condition.
